Chimeric Natural Killer Receptor-Universal T Cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Chimeric Natural Killer Receptor-Universal T Cells, covering 2024-08-23 to 2025-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma [Phase 1]